Maurizio F. D'incalci

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 174 publications

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Letrozole for hormone receptor-positive low-grade ovarian cancer: Preliminary toxicity results of a phase III trial.

Journal: Tumori

Published: December 15, 2025

Cognitive pathways to communicative-pragmatic dysfunction in schizophrenia: The role of autistic symptoms.

Cognitive pathways to communicative-pragmatic dysfunction in schizophrenia: The role of autistic symptoms.

Journal: Schizophrenia research. Cognition

Published: October 31, 2025

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.

Journal: ESMO open

Published: October 03, 2025

Selective antitumor activity of Tumor Treating Fields (TTFields) involving molecular factors in cancer cells and tumor microenvironment.

Selective antitumor activity of Tumor Treating Fields (TTFields) involving molecular factors in cancer cells and tumor microenvironment.

Journal: Translational oncology

Published: July 15, 2025

Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.

Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody.

Journal: Cancer immunology, immunotherapy : CII

Published: June 25, 2025

Correction: Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics.

Correction: Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics.

Journal: Cell death & disease

Published: May 16, 2025

Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study).

Assessment of the Mechanisms of Action of Eribulin in Patients with Advanced Liposarcoma Through the Evaluation of Radiological, Functional, and Tissue Responses: A Prospective Monocentric Study (Malibu Study).

Journal: Cancers

Published: January 26, 2025

Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB.

Malignant mesothelioma-associated inflammatory microenvironment promotes tumor progression via GPNMB.

Journal: Journal of translational medicine

Published: January 15, 2025

Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube.

Controversies in the management of serous tubal intra-epithelial carcinoma lesions of the fallopian tube.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 27, 2024

Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics.

Immune evasion mechanisms in early-stage I high-grade serous ovarian carcinoma: insights into regulatory T cell dynamics.

Journal: Cell death & disease

Published: November 13, 2024

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).

Journal: Cell death discovery

Published: September 25, 2024

HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib.

HR-SC-an academic-developed machine learning framework to classify HRD-positive ovarian cancer patients and predict sensitivity to olaparib.

Journal: ESMO open

Published: September 12, 2024

Showing 1-12 of 174

Last Updated: 09/26/2026